Successful re-ossification of calvarial defects is characteristically limited to immature animals and children less than 1-2 years of age. Conversely, skeletally mature animals demonstrate an almost universal inability to heal even small trephine defects, with bone deficits remaining present for the life of the subject. While a plethora of strategies have been developed over the past century for treating adult calvarial defects, the myriad of methods currently available reflects the inadequacies of each therapeutic technique. By combining advances in developmental biology, organogenesis, stem cell biology, bioengineering, and material sciences, however, a new paradigm for calvarial bone tissue engineering has emerged - Regenerative Medicine. Of the multitude of applications for tissue engineering and regenerative medicine, calvarial defects represent one of the most likely targets to meet with clinical success, given the alluring potential for implementation of translational therapies in the near future. This proposal seeks to significantly expand the scope of our parent grant proposal in determining the optimal design of a cell-based calvarial regenerative strategy utilizing human adipose-derived stromal cells (hASCs).
In Specific Aim 1, we will investigate the capacity of concurrent controlled exposure of hASC to exogenous rhBMP-2 and RNAi-mediated suppression of BMP antagonism over a critical window of osteogenic differentiation to enhance in vitro osteogenesis relative to independent manipulations.
In Specific Aim 2, we will assay the ability of similar manipulations of hASC to regenerate bone in vivo in our critical sized calvarial defect nude mouse model. We will employ the use of PEG-based hydrogel scaffolds to deliver the cells and determine if skeletal healing can be augmented by modulating BMP signaling via microparticle encapsulated recombinant human BMP-2 delivery and RNA interference of Noggin. We will also be able to examine the respective contributions of the implanted donor and surrounding host cells to the regenerate. Ultimately, the translational goal of this application is to realize a cell-based clinical regenerative medicine strategy to repair calvarial defects using tissue engineered bone.

Public Health Relevance

Adult animals demonstrate an almost universal inability to heal even small skull defects, with bone deficits remaining present for the life of the subject. While many strategies have been developed over the past century for treating adult skull defects, the myriad of methods currently available reflects the inadequacy of each therapeutic technique. By combining advances in developmental biology, organogenesis, stem cell biology, bioengineering, and material sciences, however, a new paradigm for bone tissue engineering has emerged - Regenerative Medicine. Of the multitude of applications for tissue engineering and regenerative medicine, adult skull defects represent one of the most likely targets to meet with clinical success, given the alluring potential for implementation of translational therapies in the near future. This Competitive Revision proposal seeks to optimize the skull regenerative strategy utilizing human fat-derived multipotent cells outlined in our parent grant through simultaneous targeted molecular manipulations of pro-osteogenic agonists and antagonists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
3R21DE019274-02S1
Application #
7836559
Study Section
Special Emphasis Panel (ZDE1-VH (31))
Program Officer
Lumelsky, Nadya L
Project Start
2008-09-01
Project End
2010-08-31
Budget Start
2009-09-25
Budget End
2010-08-31
Support Year
2
Fiscal Year
2009
Total Cost
$311,452
Indirect Cost
Name
Stanford University
Department
Surgery
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Chan, Charles K F; Gulati, Gunsagar S; Sinha, Rahul et al. (2018) Identification of the Human Skeletal Stem Cell. Cell 175:43-56.e21
Tevlin, Ruth; Seo, Eun Young; Marecic, Owen et al. (2017) Pharmacological rescue of diabetic skeletal stem cell niches. Sci Transl Med 9:
Paik, Kevin J; Maan, Zeshaan N; Zielins, Elizabeth R et al. (2016) Short Hairpin RNA Silencing of PHD-2 Improves Neovascularization and Functional Outcomes in Diabetic Wounds and Ischemic Limbs. PLoS One 11:e0150927
Keeney, Michael; Chung, Michael T; Zielins, Elizabeth R et al. (2016) Scaffold-mediated BMP-2 minicircle DNA delivery accelerated bone repair in a mouse critical-size calvarial defect model. J Biomed Mater Res A 104:2099-107
Atashroo, David A; Paik, Kevin J; Chung, Michael T et al. (2015) Assessment of viability of human fat injection into nude mice with micro-computed tomography. J Vis Exp :e52217
Chan, Charles K F; Seo, Eun Young; Chen, James Y et al. (2015) Identification and specification of the mouse skeletal stem cell. Cell 160:285-98
Chung, Michael T; Paik, Kevin J; Atashroo, David A et al. (2014) Studies in fat grafting: Part I. Effects of injection technique on in vitro fat viability and in vivo volume retention. Plast Reconstr Surg 134:29-38
Senarath-Yapa, Kshemendra; McArdle, Adrian; Renda, Andrea et al. (2014) Adipose-derived stem cells: a review of signaling networks governing cell fate and regenerative potential in the context of craniofacial and long bone skeletal repair. Int J Mol Sci 15:9314-30
Behr, Björn; Longaker, Michael T; Quarto, Natalina (2013) Absence of endochondral ossification and craniosynostosis in posterior frontal cranial sutures of Axin2(-/-) mice. PLoS One 8:e70240
Hyun, Jeong; Grova, Monica; Nejadnik, Hossein et al. (2013) Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector. Stem Cells Transl Med 2:690-702

Showing the most recent 10 out of 49 publications